13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.9M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

QUCY Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Quantum Cyber N.V. (QUCY), a Healthcare sector company. QUCY is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.9m in revenue. Based on the latest XBRL financial filings (Q1 2026), Quantum Cyber N.V. reports net income of $-5.1M, free cash flow of $-2.7M. Top institutional holders of QUCY by reported 13-F value include UBS Group AG, XTX Topco Ltd, Steward Partners Investment Advisory,, based on the most recent SEC filings. QUCY trades on the Nasdaq exchange and files with the SEC under CIK 1874252. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QUCY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Quantum Cyber N.V. directly from SEC EDGAR.

Net Income

Q1 2026

$-5.1M

Free Cash Flow

Q1 2026

$-2.7M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-39.9% YoY
$537.1KFY 2025
FY23 $895.5KFY24 $894.0KFY25 $537.1K

Net Income

+24.9% YoY
$-16.2MFY 2025
FY23 FY24 $-21.6MFY25 $-16.2M

Operating Income

+14.0% YoY
$-16.1MFY 2025
FY23 FY24 $-18.8MFY25 $-16.1M

EPS (Diluted)

+87.7% YoY
$-2.70FY 2025
FY23 FY24 $-21.91FY25 $-2.70

Total Assets

-59.8% YoY
$5.3MFY 2025
FY23 $15.4MFY24 $13.2MFY25 $5.3M

Total Debt

-6.5% YoY
$956.9KFY 2025
FY23 FY24 $1.0MFY25 $956.9K

Op. Cash Flow

+36.6% YoY
$-11.0MFY 2025
FY23 FY24 $-17.3MFY25 $-11.0M

AI Insight: QUCY Financial Trends

Pre-revenue biotech burning cash with minimal financial disclosure; Q1 2026 shows $5M net loss and negative operating cash flow.

Q1 2026 operating loss of $2M and negative operating cash flow of $3M reflect early-stage burn with no revenue reported.

Equity position improved to $5M in Q1 2026 from $1M in Q4 2025, likely driven by capital raise.

Sparse financials across 8 quarters (mostly blank rows) limit visibility into development progress and runway.

Cash burn trajectory and path to revenue inflection unknown given minimal disclosed operational metrics.

AI Insight: QUCY Ratio Trends

Insufficient data to assess trends — only leverage ratio available (D/E 1.49 in Q4 2025); all profitability and return metrics absent.

Debt-to-equity ratio stood at 1.49 as of Q4 2025; no prior quarters reported to establish trend direction.

Complete absence of OpMargin, NPM, ROE, ROA, and ROIC data limits assessment of operational efficiency and capital returns.

Get alerted when QUCY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Quantum Cyber N.V. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put QUCY on your watchlist

Track score changes the day Quantum Cyber N.V. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is QUCY a good stock to buy?

13F Pro's AI-powered analysis of Quantum Cyber N.V. (QUCY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for QUCY are available on the QUCY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own QUCY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling QUCY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Quantum Cyber N.V.'s investment landscape.